ADMA Biologics Ownership | Who Owns ADMA Biologics?


OverviewRevenueFinancialsChartTranscripts

ADMA Biologics Ownership Summary


ADMA Biologics is owned by 88.70% institutional investors, 2.55% insiders, and 8.76% retail investors. Blackrock is the largest institutional shareholder, holding 8.15% of ADMA shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.42% of its assets in ADMA Biologics shares.

ADMA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockADMA Biologics88.70%2.55%8.76%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock18.64M8.15%$208.45M
Vanguard group14.52M6.34%$162.30M
Invesco13.17M5.75%$147.25M
Nuveen asset management8.93M3.90%$99.78M
State street8.06M3.52%$90.11M
D. e. shaw6.82M2.98%$76.30M
American century companies6.05M2.65%$67.69M
Geode capital management5.24M2.29%$58.64M
Awm investment company5.10M2.23%$56.99M
Two sigma advisers, lp4.65M2.03%$52.04M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stonepine capital management1.87M19.07%$20.91M
Awm investment company5.10M7.70%$56.99M
Altium capital management lp1.51M6.89%$16.88M
Ophir asset management pty1.83M3.63%$20.47M
Miura global management300.00K3.27%$3.35M
New millennium group214.31K2.15%$3.68M
Mesirow institutional investment management1.76M1.72%$19.63M
Eam global investors660.99K1.66%$7.39M
Virtus investment advisers157.27K1.49%$1.76M
Oberweis asset management inc/2.04M1.40%$22.82M

Top Buyers

HolderShares% AssetsChange
Invesco13.17M0.03%5.37M
Perpetual3.63M0.73%3.63M
Allspring global investments2.84M0.08%2.61M
Price t rowe associates inc /md/2.08M0.00%2.02M
Fmr1.88M0.00%1.87M

Top Sellers

HolderShares% AssetsChange
Perceptive advisors2.77M0.74%-3.66M
Assenagon asset management591.68K0.02%-2.88M
State street8.06M0.00%-2.49M
Ophir asset management pty1.83M3.63%-1.60M
Stonepine capital management1.87M19.07%-1.56M

New Positions

HolderShares% AssetsChangeValue
Perpetual3.63M0.73%3.63M$62.30M
Bank of montreal /can/1.60M0.01%1.60M$17.89M
First trust advisors lp723.58K0.01%723.58K$8.09M
Healthcare of ontario pension plan trust fund578.50K0.02%578.50K$6.47M
Trexquant investment lp510.64K0.09%510.64K$5.71M

Sold Out

HolderChange
Mendota financial group-4.00
Ancora advisors-100.00
Reuter james wealth management-117.00
Abich financial wealth management-177.00
Innealta capital-213.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202430920.23%208,056,49715.00%881.42%19329.53%9618.52%
Jun 30, 202425517.51%180,834,8813.64%791.33%1497.97%8053.85%
Mar 31, 202421716.67%174,477,0703.15%771.37%13850.00%52-10.34%
Dec 31, 2023186-1.59%169,142,481-1.14%751.27%92-16.36%5826.09%
Sep 30, 20231895.00%171,085,6313.40%761.38%11025.00%46-24.59%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF15.18M6.42%-
Vanguard Total Stock Mkt Idx Inv7.00M2.96%7.37K
iShares Russell 2000 ETF6.12M2.59%-929.00
SPDR® S&P Biotech ETF5.59M2.36%-20.70K
Vanguard Institutional Extnd Mkt Idx Tr3.59M1.52%112.39K
Xtrackers MSCI World Swap ETF 1C3.15M1.33%-
T. Rowe Price Integrated US SmCapGrEq3.05M1.29%1.53M
CREF Stock R12.80M1.20%-102.61K
Fidelity Small Cap Index2.28M0.97%-19.42K
iShares S&P Small-Cap 600 Growth ETF2.19M0.93%4.27K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 22, 2024Tade Brad L. CFO and TreasurerSell$317.25K
Nov 22, 2024Grossman Adam S President and CEOSell$1.03M
Sep 09, 2024Guiheen Lawrence P.-Sell$166.19K
Aug 30, 2024Kestenberg-Messina Kaitlin M. COO and SVP, ComplianceSell$408.05K
Aug 29, 2024Grossman Jerrold B-Sell$2.36M

Insider Transactions Trends


DateBuySell
2024 Q4-2
2024 Q3-6
2024 Q2-1
2024 Q1-5
2023 Q4--

ADMA Ownership FAQ


Who Owns ADMA Biologics?

ADMA Biologics shareholders are primarily institutional investors at 88.70%, followed by 2.55% insiders and 8.75% retail investors. The average institutional ownership in ADMA Biologics's industry, Biotech Stocks , is 109.70%, which ADMA Biologics falls below.

Who owns the most shares of ADMA Biologics?

ADMA Biologics’s largest shareholders are Blackrock (18.64M shares, 8.15%), Vanguard group (14.52M shares, 6.34%), and Invesco (13.17M shares, 5.75%). Together, they hold 20.24% of ADMA Biologics’s total shares outstanding.

Does Blackrock own ADMA Biologics?

Yes, BlackRock owns 8.15% of ADMA Biologics, totaling 18.64M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 208.45M$. In the last quarter, BlackRock increased its holdings by 445.43K shares, a 2.45% change.

Who is ADMA Biologics’s biggest shareholder by percentage of total assets invested?

Stonepine capital management is ADMA Biologics’s biggest shareholder by percentage of total assets invested, with 19.07% of its assets in 1.87M ADMA Biologics shares, valued at 20.91M$.

Who is the top mutual fund holder of ADMA Biologics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ADMA Biologics shares, with 6.42% of its total shares outstanding invested in 15.18M ADMA Biologics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools